APUS 股價走勢圖
APUS 收益
Apimeds Pharmaceuticals US Inc
$1.88
0%
$0
收盤價：Apr 16, 16:00:00 GMT-4
$1.88
0%
$0
盤後：Apr 16, 18:08:26 GMT-4
返回
Apimeds Pharmaceuticals US Inc (APUS) 收益
關鍵數據
前收市價
$1.88
開盤價
$1.69
當日範圍
$1.69 - $1.88
52週區間
$1.6 - $40.31
交易量
31.5K
平均成交量
17.9K
股息收益率
--
每股盈餘 (TTM)
--
市值
$23.6M
什麼是 APUS？
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
